Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir

China Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir, Find details about China Velpatasvir, Material Velpatasvir from Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir

Model NO.
Condavo-- Velpatasvir
Name
Velpatasvir
Product Name
Velpatasvir Powder
Appearance
White Powder
Color
White Color
Test Method
HPLC UV
Storage
Cool Dry Place
Shelf Life
2 Years
Assay
99%
Grade
Pharmaceutical Grade
COA
Available
Mf
C49h54n8o8
CAS
1377049-84-7
Density
1.314±0.06 g/cm3(Predicted)
Psa
193.10000
Logp
8.38910
Trademark
Condavo
Transport Package
1kg/ Aluminium Bag or 25kg/Drum; as Required
Specification
99%
Origin
Shaanxi
Model NO.
Condavo-- Velpatasvir
Name
Velpatasvir
Product Name
Velpatasvir Powder
Appearance
White Powder
Color
White Color
Test Method
HPLC UV
Storage
Cool Dry Place
Shelf Life
2 Years
Assay
99%
Grade
Pharmaceutical Grade
COA
Available
Mf
C49h54n8o8
CAS
1377049-84-7
Density
1.314±0.06 g/cm3(Predicted)
Psa
193.10000
Logp
8.38910
Trademark
Condavo
Transport Package
1kg/ Aluminium Bag or 25kg/Drum; as Required
Specification
99%
Origin
Shaanxi
Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir
Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir
 
Product Description

Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material VelpatasvirPurity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir
Product NameVelpatasvir
AppearanceWhite Powder
CAS No1377049-84-7
MFC49H54N8O8
velpatasvir is an NS5A inhibitor (by Gilead) which is used together with sofosbuvir in the treatment of hepatitis C infection of all six major genotypes.
Velpatasvir is a small molecule direct-acting antiviral used in the treatment of hepatitis C in combination with sofosbuvir. Velpatasvir prevents viral replication by inhibiting non-structural protein 5A (NS5A) 4.

 
Sample Display
Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material VelpatasvirPurity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material VelpatasvirVelpatasvir is innovated by Gilead to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients. Velpatasvir is a Direct-Acting Antiviral (DAA) medication used together with Sofosbuvir. The mechanism of action is as a Breast Cancer Resistance Protein Inhibitor, and P-Glycoprotein Inhibitor, and Organic Anion Transporting Polypeptide 1B1 Inhibitor, and Organic Anion Transporting Polypeptide 1B3 Inhibitor, and Organic Anion Transporting Polypeptide 2B1 Inhibitor. It blocks NS5A, a protein necessary for hepatitis C virus replication assembly.
Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir A complex organic heteropentacyclic compound that is a hepatitis C virus nonstructural protein
5A inhibitor used in combination with sofosbuvir (under the brand name Epclusa) for treatment of patients with
chronic hepatitis C of all six major genotypes.

 
Specification

Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material VelpatasvirPurity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir
Packaging & Shipping

Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir
Certifications

Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir
Our Team

Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir
About Us

Purity Velpatasvir Powder CAS 1377049-84-7 Velpatasvir Material Velpatasvir